Ratratutide, also known as IMC-005, is an investigational medication being developed for the treatment of:
## Indications
1. Type 2 diabetes: To improve glycemic control and reduce HbA1c levels.
2. Obesity: To aid in weight loss and improve metabolic health.
## Mechanism of Action
Ratratutide is a dual agonist of:
1. Glucagon-like peptide-1 (GLP-1) receptor: Enhances insulin secretion, suppresses glucagon secretion, and slows gastric emptying.
2. Glucagon receptor: Reduces glucose production in the liver and improves insulin sensitivity.
## Benefits
1. Improved glycemic control: Reduces HbA1c levels and improves blood sugar control.
2. Weight loss: Aids in significant weight loss and improves metabolic health.
3. Cardiovascular benefits: May reduce the risk of major adverse cardiovascular
